Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In consultation
In consultation: Guidance and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Consultation end date
Consultation end date
From date
To date
Apply date filters
Type
Type
Guidance (20)
Quality standard (1)
Guidance programme
Guidance programme
Clinical guidelines (3)
Health technology evaluations (1)
Interventional procedures guidance (1)
NICE general (1)
NICE guidelines (4)
Quality standard (1)
Technology appraisal guidance (13)
Apply filters
Showing 11 to 20 of 21
Sort by
Date
Title
Apply sorting
Guidance and quality standards in consultation
Title
Consultation
Type
Consultation end date
Perioperative care in adults
Quality standard consultation
Quality standard
6 February 2026
MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor
Draft scope consultation
Interventional procedures guidance
5 February 2026
Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when an autologous stem cell transplant is suitable [ID6249]
Draft guidance
Technology appraisal guidance
4 February 2026
Upadacitinib for treating giant cell arteritis [ID6299]
Draft guidance
Technology appraisal guidance
4 February 2026
Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more systemic treatments [ID6388]
Draft guidance
Technology appraisal guidance
3 February 2026
Artificial Intelligence assisted echocardiography to support diagnosis of heart failure: Early Value Assessment
Draft guidance
Health technology evaluation
3 February 2026
Anaphylaxis: assessment and referral after emergency treatment
Surveillance consultation
NICE guideline
3 February 2026
Suspected Cancer: recognition and referral (update)
Draft guidance consultation
NICE guideline
2 February 2026
Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable [ID3843]
Draft guidance
Technology appraisal guidance
30 January 2026
Statement of intent on NICE's approach to ongoing evaluations ahead of proposed changes to NICE's standard cost-effectiveness thresholds
NICE general consultation
NICE general
30 January 2026
Previous page
1
Current page
2
3
Page
2
of
3
Next page
Results per page
10
25
50
All
Back to top